Ben Sasse's latest pancreatic cancer update comes amid his stark warning about America's future

Former Nebraska Senator Ben Sasse announced on January 15, 2026, that tumors from his metastatic pancreatic cancer shrank by more than 80 percent while undergoing a clinical trial treatment. Sasse, who resigned from the Senate in 2022 and currently serves as president of the University of Florida, disclosed the medical update publicly. He also made public statements regarding China and artificial intelligence, though specific details of those statements were not provided in the available information.

Next story